Abu-Abeid Subhi, MD, Niv Pencovich, MD, PhD, Yonatan Lessing, MD, Marian Khatib, MD. tasmc
BACKGROUND: Although single anastomosis gastric bypass (SAGB) is a promising bariatric procedure with various benefits, it is yet to gain wide acceptance and routinely performed only in specialized tertiary bariatric centers. Here we describe a single surgeon experience in SAGB with emphasis on the surgical safety and efficacy.
METHODS: Retrospective analysis of all patients who underwent SAGB between January 2015 and July 2016 was performed. All procedures were performed by a single bariatric surgeon. Patient demographics, obesity related co-morbidities, operative and postoperative data, as well as first year outcomes were collected and analyzed.
RESULTS: Five hundred and thirty-two patients underwent laparoscopic SAGB ( 320 female, average age 41.7 ± 12 range 13-72 years, BMI = 41.8 ± 5.6). Prior bariatric surgery was performed in 126 patients (23.7%). One hundred and twenty-five patients (23.4%) suffered from diabetes mellitus with average HbA1C of 8.8.
No conversions to an open approach were required.
The average length of hospital stay was 2.2 ± 0.84 days (range 1-10 days). Five patients (1.1%) suffered from major postoperative complications that necessitated reoperation within 30 days from the primary surgery. These consisted of anastemotic leaks in 1 patient, postoperative bleeding in 3 patients, and early intestinal obstruction in 1 patient. No readmissions were recorded following initial discharge. No patient died during or following surgery.
Weight loss showed a consistent trend over the follow-up period of 1 year with average EWL of 44.3% after 3 month, 67.9% after 6 month, 73.8% after 9 month and 83.3% EWL after one year. T2D has shown partial or complete remission: A1C levels after 3 month was 6.2, 6 month 5.5, 9 month 5.3 and 12 month 5.2.
CONCLUSION: SAGB is safe in both primary and revision bariatric surgery with accepted rate of postoperative morbidities. Short term weight loss and an improvement of obesity-related clinical parameters are favorable, however long term follow-up is warranted.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 79963
Program Number: P525
Presentation Session: Poster (Non CME)
Presentation Type: Poster
